pertussis

Documents about pertussis

• A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in Hungary#891674ClinicalTrials.gov
• Pertussis Challenge Study in Adults Vaccinated With BPZE1#353327ClinicalTrials.gov
• Pertussis Immunization Programs in Low Income Countries#831074ClinicalTrials.gov
• Gambia Pertussis Study (GaPs)#152490ClinicalTrials.gov
• Bordetella Pertussis Carriage in College-aged Students#901051ClinicalTrials.gov
• Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine#356518ClinicalTrials.gov
• 3-year Follow-up After a Single Dose Acellular Pertussis Vaccination#174972ClinicalTrials.gov
• 10-year Follow-up After a Single Dose Acellular Pertussis Vaccination#180198ClinicalTrials.gov
• 5-year Follow-up After a Single Dose Acellular Pertussis Vaccination#226350ClinicalTrials.gov
• The Feasibility of Pertussis Immunization in a Canadian Emergency Department#363662ClinicalTrials.gov
• Pertussis Immunization Programs in Low Income Countries - Ivory Coast#907880ClinicalTrials.gov
• How to improve pertussis vaccination in pregnancy: a European expert review#191807IRIS
• Pertussis and Meningitis C Concomitant Vaccination in Adolescents#307327ClinicalTrials.gov
• Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Adults#160172ClinicalTrials.gov
• Immunological insights into why pertussis continues to be endemic#478489Europe PMC
• Maternal Pertussis Wholecell Responses#837244ClinicalTrials.gov
• Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults#874216ClinicalTrials.gov
• Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.#249680ClinicalTrials.gov
• Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants#867779ClinicalTrials.gov
• Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers#353334ClinicalTrials.gov
• Impact of Bacterial Expression and Immune Response in the Severity of Pertussis#870455ClinicalTrials.gov
• Influencing factors for severe pertussis among Chinese children: A meta-analysis#4523Europe PMC
• First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine#394598ClinicalTrials.gov
• Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control#981914ClinicalTrials.gov
• Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.#991837ClinicalTrials.gov
• The PertADO Geneva Trial#261330ClinicalTrials.gov
• Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine#136432ClinicalTrials.gov
• Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine#272433ClinicalTrials.gov
• Translocation of membrane-active peptides from the Bordetella pertussis CyaA toxin#26249HAL (France)
• Quantifying the impact of vaccination on pertussis dynamics in Sweden#428195PLOS
• Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.#911927ClinicalTrials.gov
• Transmission patterns of pertussis in school-based clustered outbreaks: A retrospective analysis in Zhejiang Province, China, 2024#120089Europe PMC
• IS481-based pertussis positivity transition from preschool to school-aged children and the#355252PubMed
• Trends in Pertussis Incidence in Georgia from 2010 – 2020 Based on the 2020 CSTE/CDC Case Definition#492534ScholarWorks@GSU
• Pertussis Immunisation and Food Allergy#329578ClinicalTrials.gov
• Post Market Surveillance for Infanrix™#424229ClinicalTrials.gov
• The Ongoing Challenge of Pertussis in Eastern and Northern Europe: Recommendations from the Global Pertussis Initiative#145137Springer Nature OA
• A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)#180199ClinicalTrials.gov
• Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea#343702ClinicalTrials.gov
• Effectiveness of Adacel Vaccination in Pregnancy at Preventing Pertussis in Infants < 2 Months of Age in the United States#870988ClinicalTrials.gov
• Effectiveness of DTaP-IPV//PRP-T vaccine against pertussis among infants and toddlers in Zhejiang, China: a retrospective cohort study#5198Europe PMC
• Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older#854080ClinicalTrials.gov
• Screening Epitopes Through Comparative Analysis of Children and Mice Immune Responses to Pertussis Toxin Subunits (S1-S5) Induced by Whole-Cell Pertussis Vaccination.#232440NCBI PubMed Central
• Duration of Protection: GSK DTaP Vaccines#831420ClinicalTrials.gov
• Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis®#181607ClinicalTrials.gov
• Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia#332812ClinicalTrials.gov
• Variability in the Diagnostic Criteria for Severe Pertussis#464376HAL (France)
• Protecting Pregnant Women From Infectious Diseases#980253ClinicalTrials.gov
• Confirmatory Study of BK1310 in Healthy Infants#906201ClinicalTrials.gov
• A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)#992608ClinicalTrials.gov